ProxyMiner / Company

JOHNSON & JOHNSONJNJ

Latest proxy: 2026 · view on SEC ↗ · CIK 0000200406

CEO total pay

$32,758,111

J. Duato · 2025

Say on pay

92%

Latest disclosed shareholder vote

CEO pay ratio

Item 402(u)

360 to 1

Item 402(u) section may live outside the CD&A

Compensation committee

CD&A

Compensation & Benefits Committee

Per the latest proxy

Filings indexed: 2 · 2026 · 2025

Executive pay

What did they pay them?

From the Summary Compensation Table. Pay mix and YoY are computed from these rows.

ExecutiveRoleTotalYoYPay mixSalaryStockCash incentiveOther
J. Duato2025 compensation
Chairman/CEO
$32,758,111 35%
92% at-risk
$1,600,000$15,028,948$4,298,700$601,231
J. Wolk2025 compensation
EVP, CFO
$14,405,442 14%
89% at-risk
$1,240,646$6,263,486$1,860,560$115,222
J. Taubert2025 compensation
EVP, WWC Innovative Medicine
$14,030,063 25%
89% at-risk
$1,220,308$6,160,665$2,002,750$89,963
J. Reed2025 compensation
EVP, Innovative Medicine, R&D
$12,214,062 31%
88% at-risk
$1,220,308$6,160,665$1,810,000$135,076
T. Schmid2025 compensation
EVP, WWC, MedTech
$9,336,765 21%
86% at-risk
$942,308$3,422,473$1,507,800$88,059

Pay mix: base cash incentive equity other

CD&A excerpt

Compensation discussion & analysis

Opening passage of the loaded filing's CD&A. Use Ask below to query the full text with citations.

522025 Executive compensation summary2025 NEOs52Our Credo522025 Compensation highlightsJoaquin DuatoChairman of the Board andChief Executive OfficerJoseph WolkExecutive Vice President,Chief Financial OfficerJennifer TaubertExecutive Vice President, WorldwideChairman, Innovative MedicineJohn Reed, M.D., Ph.D.Executive Vice President, Innovative Medicine, R&DTim SchmidExecutive Vice President, Worldwide Chairman, MedTech542025 Say on Pay results and shareholder engagement56Compensation governance best practices572025 Executive compensation57Guiding principles58Components of executive compensation64Compensation decisions for 2025 performance64Total direct compensation decisions66NEO performance and compensation summaries66CEO performance67Compensation decisions for 2025 CEO performance67Other named executive officer performance70Executive compensation decision process70Importance of Our Credo values in assessing performance70Assessing "the what" and "the how"70Aligning compensation to "the what" and "the how"71Governance of executive compensation72Peer groups for pay and performance75Additional information concerning executive compensation75No employment agreements with named executiv

Read the full CD&A on SEC.gov ↗

Peer comparison

Who they benchmark against

Click any peer to jump to their proxy. Peers we haven't ingested yet kick off an import on click.

Governance

Policy guardrails

  • hedging

    prohibited

    Our Policy Against Pledging, Hedging and Short Selling of Company Stock prohibits directors and executive officers from pledging, entering into hedging arrangements, short selling or transacting in derivative instruments

  • pledging

    prohibited

    Our Policy Against Pledging, Hedging and Short Selling of Company Stock prohibits directors and executive officers from pledging, entering into hedging arrangements, short selling or transacting in derivative instruments

  • clawback

    present

    recoupment policy applicable to our named executive officers

  • stock ownership guidelines

    present

    Stock ownership guidelines for named executive officers

  • compensation consultant

    independent

    independent compensation consultant reporting directly to the Committee

  • compensation committee

    Compensation & Benefits Committee

    The table below lists factors the Compensation & Benefits Committee considers in its review

Performance markers

Metric facts

  • revenue

    $1 million

    than in previous years. For federal income taxes, compensation is an expense that is fully tax-deductible for almost all our U.S. employees. Following the 2017 tax reform, annual compensation in excess of $1 million paid

  • say on pay

    92%

    votes cast in favor. We believe this outcome reflects our sustained engagement with investors and disciplined, multi‑year refinements to our NEO pay program. We describe our shareholder engagement in detail on page 38. 9

  • ceo pay ratio

    360 to 1

    CEO pay ratio Ratio of the annual total compensation of the median-paid employee to the CEO The annual total compensation of our median-paid employee on a worldwide basis for 2025 was $91,000. The annual total compensati

Ask

Anything about JOHNSON & JOHNSON’s 2026 proxy

Answers are grounded in the loaded filing and cite specific artifacts. Bring your own free Google AI Studio key.

Loading the Ask interface…